Why did NICE not Recommend AI for CXR Reading in the UK?
Seminars in Roentgenology · 2026-07 · 151013
DOI: 10.1016/j.ro.2026.151013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Roentgenology, 2026-07. Verfasst von Lucy Gregory und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hardian Health, UK. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
The National Institute for Health and Care Excellence (NICE), which advises the National Health Service (NHS) on cost-effective resource allocation, introduced its Early Value Assessment (EVA) pathway in 2020 to accelerate access to promising digital and artificial intelligence (AI) technologies while further evidence is generated. However, one of the first EVA cohorts not to receive a conditional recommendation comprised 13 AI tools designed to support interpretation of chest X-rays (CXR) for suspected lung cancer in primary care referrals. This manuscript examines the rationale for that decision through narrative policy analysis of NICE guidance and committee documentation, contextualized within the UK health technology assessment framework.
Autor:innen und Institutionen
- Hardian Health, UK.
- Hardian Health, UK. Electronic address: hugh@hardianhealth.com.
Zitieren
APA
Gregory, L., & Harvey, H. (2026). Why did NICE not Recommend AI for CXR Reading in the UK?. Seminars in Roentgenology, 151013. https://doi.org/10.1016/j.ro.2026.151013
Vancouver
Gregory L, Harvey H. Why did NICE not Recommend AI for CXR Reading in the UK?. Seminars in Roentgenology. 2026:151013. doi:10.1016/j.ro.2026.151013
BibTeX
@article{Gregory2026,
author = {Gregory, Lucy and Harvey, Hugh},
title = {Why did NICE not Recommend AI for CXR Reading in the UK?},
journal = {Seminars in Roentgenology},
year = {2026},
pages = {151013},
doi = {10.1016/j.ro.2026.151013}
}
EUVIMED